Complications of Transsphenoidal Surgery:Results of a National Survey, Review of the Literature, and Personal Experience
Neurosurg 40:225-236, Ciric,I.,et al, 1997
Arterial Injuries in Transsphenoidal Surgery for Pituitary Adenoma:The Role of Angiography and Endovascular Treatment
ANJR 18:655-665, Raymond,J.,et al, 1997
Clinicopath Conf
Noncaseating Granulomas Consistent with Sarcoidosis, Case 37-1996, NEJM 335:1668-1674996., , 1996
Interferon Beta in Multiple Sclerosis
BMJ 313:1159, 1157, 1195996., Richards,R.G., 1996
Neutralizing Antibodies During Treatment of Multiple Sclerosis with Interferon Beta-1b
IFNB MS Study Group & UBC MS. MRI Analysis Group, Neurol 47:889-8946., , 1996
Guidelines for Physicians with Patients on IFNB-1b:The Use of an Assay for Neutralizing Antibodies (NAB)
Neurol 47:865-866, Paty,D.,et al, 1996
Adverse Cerebral Outcomes After Coronary Bypass Surgery
NEJM 335:1857-1863, Roach,G.W.,et al, 1996
Low-Dose Oral Methotrexate in Chronic Progressive Multiple Sclerosis:Analyses of Serial MRIs
Neurol 47:1153-1157, Goodkin,D.E.,et al, 1996
Linomide Reduces the Rate of Active Lesions in Relapsing-Remitting Multiple Sclerosis
Neurol 47:895-900, Anderson,O.,et al, 1996
Treatment with Oral 3, 4 Diaminopyridine Improves Leg Strength in Multiple Sclerosis Patients
Neurol 47:1457-1462, Bever,C.T.,et al, 1996
Treatment of Refractory Urge Urinary Incontinence with Sacral Spinal Nerve Stimulation in Multiple Sclerosis Patients
Lancet 348:717-719, Bosch,J.L.&Broen,J., 1996
An Analysis of Perioperative Surgical Mortality and Morbidity in the Asymptomatic Carotid Atherosclerosis Study
Stroke 27:2216-2224, Young,B.,et al, 1996
Treatment of Advanced Parkinson's Disease by Posterior GPi Pallidotomy:1-Year Results of a Pilot Study
Ann Neurol 40:355-366, 3411996., Baron,M.S.,et al, 1996
Progressive Multifocal Leukoencephalopathy:Clinical and MR Response to Treatment
AJNR 17:597-600, Garrels,K.,et al, 1996
Multifocal Motor Neuropathy
JNNP 60:599-603, Nobile-Orazio,E., 1996
A Systematic Review of the Risks of Stroke & Death Due to Endarterectomy for Symptomatic Carotid Stenosis
Stroke 27:260-265, Rothwell,P.M.,et al, 1996
A Systematic Comparison of Risks of Stroke & Death Due to Carotid Endarterectomy for Symptomatic & Asympt Stenosis
Stroke 27:266-269, Rothwell,P.M.,et al, 1996
Management of Patients Receiving Interferon Beta-1b for MS:Report of a Consensus Conf
Neurol 46:12-18, Lublin,F.D.,et al, 1996
Horner's Syndrome after Coronary Artery Bypass Surgery
Neurol 46:181-184, Barbut,D.,et al, 1996
Stereotactic Brain Biopsy in Human Immunodeficiency Virus-Infected Patients
Arch Int Med 156:565-568, Luzzati,R.,et al, 1996
Brain Damage and Postoperative Hyponatremia:The Role of Gender
Neurol 46:323-328, Aruy,J.C.&Arieff,A.I., 1996
Wernicke's Encephalopathy After Vertical Banded Gastroplasty for Morbid Obesity
BMJ 312:434, Seehra,H.,et al, 1996
Valproic Acid Hepatic Fatalities. III. U. S. Experience Since 1986
Neurol 46:465-469, Bryant,A.E.&Dreifuss,F., 1996
Treatment of Secondary Progressive Multiple Sclerosis with the Immunomodulator Linomide:Study with Monthly MRI Evaluation
Neurol 47:341-346, Karussis,D.M.,et al, 1996
Impact of Aerobic Training on Fitness and Quality of Life in Multiple Sclerosis
Ann Neurol 39:432-441, 4221996., Petajan,J.H.,et al, 1996
Palliative Care in Neurology
Neurol 46:870-872, 5981996., Bernat,J.L.,et al, 1996
Is Chronic Respiratory Failure in Neuromuscular Diseases Worth Treating
JNNP 61:1-3, Shneerson,J.M., 1996
Lorazepam and Midazolam in the Intensive Care Unit:A Randomized, Prospective, Multicenter Study of Hemodynamics, Oxygen Transport, Efficacy, and Cost
Crit Care Med 24:222-228, Cernaianu A.C.,et al, 1996
Long-Term Prog & Effect of Endart in Pts with Sympt Severe Carotid Stenosis & Contra Carotid Sten or Occl:NASCET
J. Neurosurg 83:778-782, Gasecki,A.P.,et al, 1995
The Natural History of Progressive Mutlifocal Leukoencephalopathy in Patients with AIDS
Clin Inf Dis 20:1305-1310, Fong,I.W.,et al, 1995
Fatigue Therapy in Multiple Sclerosis:A Double-blind, Randomized, Parallel Trial of Amantadine, Pemoline & Placebo
Neurol 45:1956-1961, Krupp,L.B.,et al, 1995
Combined System Disease after Nitrous Oxide Anesthesia:A Case Report
Neurol 45:1224-1225, McMorrow,A.M.,et al, 1995
'Anesthesia Paresthetica':Nitrous Oxide-Induced Cobalamin Deficiency
Neurol 45:1608-1610, 14351995., Kinsella,L.J.&Green,R., 1995
Improvement of Multifocal Motor Neuropathy During Long-Term Weekly Treatment with Human Immunoglobulin
Neurol 45:987-988, van den Berg,L.H.,et al, 1995
Multifocal Motor Neuropathy with Conduction Block:A Study of 24 Patients
JNNP 59:38-44, Bouche,P.,et al, 1995
Surgical Management of Spinal Epidural Hematoma:Relationship Between Surgical Timing and Neurological Outcome
J Neurosurg 83:1-7, Lawton,M.T.,et al, 1995
Elective Intubation for Neurologic Deterioration after Stroke
Neurol 45:640-644, Grotta,J.,et al, 1995
Postoperative Neurologic Complications after Open Heart Surgery on Young Infants
Arch Pediatr Adolesc Med 149:764-768, Miller,G.,et al, 1995
Reflex Sympathetic Dystrophy
BMJ 310:1645-1648, Paice,E., 1995
Interferon Beta-1b in the Trtm of MS:Outcome of the Randomized Controlled Trial
IFNB Study Gr, Neurol 45:1277-12851995., , 1995
Effect of Interferon-B on Blood-Brain Barrier Disrupt Demonst by Contrast MRI in Relapsing-Remitting MS
Ann Neurol 37:611-619, Stone,L.A.,et al, 1995
Copolymer 1 Reduces Relapse Rate & Improves Disability in Relapsing-Remitting MS:Multictr Trial
Neurol 45:1268-1276, Johnson,K.P.,et al, 1995
Measuring Patient-Centered Outcomes in Neurologic Disease, Extending the Q-TWIST Method
Arch Neurol 52:754-762, Schwartz,C.,et al, 1995
Mild Traumatic Brain Injury:Pathophysiology, Natural History, and Clinical Management
Neurol 45:1253-1260, 12511995., Alexander,M.P., 1995
Therapeutic Considerations in Patients with Refractory Neurosarcoidosis
Arch Neurol 52:875-879, Agbogu,B.N.,et al, 1995
The Eosinophilia-Myalgia Syndrome:Status of 205 Patients and Results of Treatment 2 Years After Onset
Ann Int Med 122:851-855, Hertzman,P.A.,et al, 1995
The Interferons:Biological Effects, Mechanisms of Action, and Use in Multiple Sclerosis
Ann Neurol 37:7-15, Weinstock-Guttman,B.,et al, 1995
New Treatments for Multiple Sclerosis
BMJ 310:345-346, McDonald,W.I., 1995
Low-Dose (7. 5mg) Oral Methotrexate Reduces the Rate of Progression in Chronic Progressive Multiple Sclerosis
Ann Nuerol 37:30-40, 51995., Goodkin,D.E.,et al, 1995
Devel & Neurologic Status of Children after Heart Surgery with Hypothermic Circ Arrest or Low-Flow Cardiopul Bypass
NEJM 332:549-555, Bellinger,D.C.,et al, 1995